Bumper Offer - Urjas oil Just @ Rs. 1
Gabantip AT 300 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Secondary and off-label uses of Gabantip AT 300 Tablet have also been mentioned below.
The optimal dosage of Gabantip AT 300 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Some other side effects of Gabantip AT 300 Tablet have been listed ahead. Such side effects of Gabantip AT 300 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Gabantip AT 300 Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Gabantip AT 300 Tablet related warnings talks about Gabantip AT 300 Tablet's effects on the liver, heart and kidney.
Gabantip AT 300 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Heart Failure, Arrhythmia are examples of such conditions. The section on Gabantip AT 300 Tablet contraindications lists all such conditions.
Drug reaction of Gabantip AT 300 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Gabantip AT 300 Tablet is considered not safe while driving, and is not addictive.
Gabantip AT 300 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Gabantip AT 300 Tablet is used -
Moderate
Mild
Is the use of Gabantip AT 300 Tablet safe for pregnant women?
Gabantip AT can have harmful effects in pregnant women. If you experience any discomfort after using Gabantip AT, then discontinue the use and take your doctor's advice.
Is the use of Gabantip AT 300 Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Gabantip AT. Immediately discontinue Gabantip AT if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Gabantip AT 300 Tablet on the Kidneys?
Gabantip AT rarely harms the kidneys.
What is the effect of Gabantip AT 300 Tablet on the Liver?
Gabantip AT does not damage the liver.
What is the effect of Gabantip AT 300 Tablet on the Heart?
Gabantip AT is not harmful for the heart.
Gabantip AT 300 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gabantip AT 300 Tablet unless your doctor advises you to do so -
Is this Gabantip AT 300 Tablet habit forming or addictive?
You may get addicted to Gabantip AT 300 Tablet. Therefore, before taking it, consult your doctor.
Interaction between Food and Gabantip AT 300 Tablet
Taking Gabantip AT 300 Tablet with food does not cause any problems.
Interaction between Alcohol and Gabantip AT 300 Tablet
Consumption of alcohol and Gabantip AT 300 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amitriptyline Hydrochloride
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454,458
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 145-147
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
